FDA Inspection 1069533 — Novum Pharmaceutical Research Services
The FDA completed an inspection of Novum Pharmaceutical Research Services on Sep 13, 2018 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Houston, TX (United States)
Additional Details
Clinical BA/BE